Found: 1395
Select item for more details and to access through your institution.
In situ stoichiometry amounts of p62 and poly-ubiquitin exceed the increase of alpha-synuclein during degeneration of catecholamine cells induced by autophagy inhibition in vitro.
- Published in:
- Journal of Neural Transmission, 2024, v. 131, n. 12, p. 1397, doi. 10.1007/s00702-024-02795-x
- By:
- Publication type:
- Article
The Impact of Probiotics on Clinical Symptoms and Peripheral Cytokines Levels in Parkinson's Disease: Preliminary In Vivo Data.
- Published in:
- Brain Sciences (2076-3425), 2024, v. 14, n. 11, p. 1147, doi. 10.3390/brainsci14111147
- By:
- Publication type:
- Article
Neuroimaging in Parkinsonian Disorders.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Association of polymorphism in rs2736990 of the α-synuclein gene with Parkinson's disease in a Chinese population.
- Published in:
- Neurology India, 2013, v. 61, n. 4, p. 360, doi. 10.4103/0028-3886.117595
- By:
- Publication type:
- Article
Conformational Equilibria in Monomeric -Synuclein at the Single-Molecule Level.
- Published in:
- PLoS Biology, 2008, v. 6, n. 1, p. e6, doi. 10.1371/journal.pbio.0060006
- By:
- Publication type:
- Article
DJ-1 Is a Redox-Dependent Molecular Chaperone That Inhibits α-Synuclein Aggregate Formation.
- Published in:
- PLoS Biology, 2004, v. 2, n. 10, p. 1, doi. 10.1371/journal.pbio.0020362
- By:
- Publication type:
- Article
Inhibition of α‐Synuclein Amyloid Fibril Elongation by Blocking Fibril Ends.
- Published in:
- Angewandte Chemie, 2018, v. 130, n. 20, p. 5792, doi. 10.1002/ange.201801071
- By:
- Publication type:
- Article
Role of N-terminal methionine residues in the redox activity of copper bound to alpha-synuclein.
- Published in:
- Journal of Biological Inorganic Chemistry (JBIC), 2016, v. 21, n. 5/6, p. 691, doi. 10.1007/s00775-016-1376-5
- By:
- Publication type:
- Article
Neurodegeneration: Aggregates feel the strain.
- Published in:
- Nature, 2015, v. 522, n. 7556, p. 296, doi. 10.1038/nature14526
- By:
- Publication type:
- Article
Neurodegeneration: Antibodies fight Parkinson's.
- Published in:
- Nature, 2014, v. 511, n. 7509, p. 267, doi. 10.1038/511267a
- Publication type:
- Article
Higher alpha-synuclein aggregate density does not lead to more severe dopaminergic cell loss in the AAV-mediated overexpression model of Parkinson's Disease: A timecourse study.
- Published in:
- Journal of Research in Pharmacy, 2021, v. 25, n. 3, p. 352, doi. 10.29228/jrp.25
- By:
- Publication type:
- Article
Author Correction: α-Synuclein emulsifies TDP-43 prion-like domain—RNA liquid droplets to promote heterotypic amyloid fibrils.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
α-Synuclein emulsifies TDP-43 prion-like domain—RNA liquid droplets to promote heterotypic amyloid fibrils.
- Published in:
- Communications Biology, 2023, v. 6, n. 1, p. 1, doi. 10.1038/s42003-023-05608-1
- By:
- Publication type:
- Article
Salivary α‐Synuclein as a Candidate Biomarker of Parkinsonism in 22q11.2 Deletion Syndrome.
- Published in:
- Movement Disorders Clinical Practice, 2024, v. 11, n. 7, p. 808, doi. 10.1002/mdc3.14046
- By:
- Publication type:
- Article
α‐Synuclein Seed Amplification Assays in the Diagnosis of Synucleinopathies Using Cerebrospinal Fluid—A Systematic Review and Meta‐Analysis.
- Published in:
- Movement Disorders Clinical Practice, 2023, v. 10, n. 5, p. 737, doi. 10.1002/mdc3.13710
- By:
- Publication type:
- Article
Guided Mode Induced Surface Phase Mutation for Enhanced SPR Biosensor with Dual‐Parameters Interrogation.
- Published in:
- Advanced Materials Interfaces, 2023, v. 10, n. 34, p. 1, doi. 10.1002/admi.202300354
- By:
- Publication type:
- Article
ADVANCING PARKINSON’S DISEASE DETECTION WITH FLISA: A NOVEL APPROACH TARGETING MISFOLDED ALPHA-SYNUCLEIN.
- Published in:
- Indian Drugs, 2024, v. 61, n. 3, p. 25, doi. 10.53879/id.61.03.14385
- By:
- Publication type:
- Article
Combined Mesenchymal Stem Cell-Derived Exosomes and H2S Ameliorated the Neurodegenerative Changes in Parkinson's Disease: Implication of PI3K/AKT Signaling Pathway.
- Published in:
- Egyptian Academic Journal of Biological Sciences, C Physiology & Molecular Biology, 2022, v. 14, n. 2, p. 203, doi. 10.21608/EAJBSC.2022.266863
- By:
- Publication type:
- Article
Correction: Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Correction: Retina-to-brain spreading of α-synuclein after intravitreal injection of preformed fibrils.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Plant poisoning leads to alpha-synucleinopathy and neuromelanopathy in kangaroos.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-53396-8
- By:
- Publication type:
- Article
Identifying a glucose metabolic brain pattern in an adeno-associated viral vector based rat model for Parkinson's disease using <sup>18</sup>F-FDG PET imaging.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-48713-0
- By:
- Publication type:
- Article
Alpha-synuclein is a DNA binding protein that modulates DNA repair with implications for Lewy body disorders.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-47227-z
- By:
- Publication type:
- Article
Pain-Free Alpha-Synuclein Detection by Low-Cost Hierarchical Nanowire Based Electrode.
- Published in:
- Nanomaterials (2079-4991), 2024, v. 14, n. 2, p. 170, doi. 10.3390/nano14020170
- By:
- Publication type:
- Article
Canthin-6-One Accelerates Alpha-Synuclein Degradation by Enhancing UPS Activity: Drug Target Identification by CRISPR-Cas9 Whole Genome-Wide Screening Technology.
- Published in:
- Frontiers in Pharmacology, 2019, p. N.PAG, doi. 10.3389/fphar.2019.00016
- By:
- Publication type:
- Article
Alpha-Synuclein in the Regulation of Brain Endothelial and Perivascular Cells: Gaps and Future Perspectives.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2021.611761
- By:
- Publication type:
- Article
Dysbiosis of the gut microbiota and its effect on α-synuclein and prion protein misfolding: consequences for neurodegeneration.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2024, p. 01, doi. 10.3389/fcimb.2024.1348279
- By:
- Publication type:
- Article
Experimental models of gut‐first Parkinson's disease: A systematic review.
- Published in:
- Neurogastroenterology & Motility, 2023, v. 35, n. 8, p. 1, doi. 10.1111/nmo.14604
- By:
- Publication type:
- Article
Probing the surface charge of condensates using microelectrophoresis.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-47885-2
- By:
- Publication type:
- Article
Phosphorylation and O-GlcNAcylation at the same α-synuclein site generate distinct fibril structures.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-46898-1
- By:
- Publication type:
- Article
Spatial transcriptomics reveals molecular dysfunction associated with cortical Lewy pathology.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-47027-8
- By:
- Publication type:
- Article
A SPLICS reporter reveals α-synuclein regulation of lysosome-mitochondria contacts which affects TFEB nuclear translocation.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-46007-2
- By:
- Publication type:
- Article
Reduced progranulin increases tau and α-synuclein inclusions and alters mouse tauopathy phenotypes via glucocerebrosidase.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-45692-3
- By:
- Publication type:
- Article
Reduced progranulin increases tau and α-synuclein inclusions and alters mouse tauopathy phenotypes via glucocerebrosidase.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-45692-3
- By:
- Publication type:
- Article
Brain-to-gut trafficking of alpha-synuclein by CD11c<sup>+</sup> cells in a mouse model of Parkinson's disease.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-43224-z
- By:
- Publication type:
- Article
α-Synuclein aggregates amplified from patient-derived Lewy bodies recapitulate Lewy body diseases in mice.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-42705-5
- By:
- Publication type:
- Article
Glucocerebrosidase mutations disrupt the lysosome and now the mitochondria.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-42107-7
- By:
- Publication type:
- Article
Prosaposin maintains lipid homeostasis in dopamine neurons and counteracts experimental parkinsonism in rodents.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-41539-5
- By:
- Publication type:
- Article
Elevated concentrations cause upright alpha-synuclein conformation at lipid interfaces.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-39843-1
- By:
- Publication type:
- Article
Sex-dependent neuronal effects of α-synuclein reveal that GABAergic transmission is neuroprotective of sleep-controlling neurons.
- Published in:
- Cell & Bioscience, 2023, v. 13, n. 1, p. 1, doi. 10.1186/s13578-023-01105-4
- By:
- Publication type:
- Article
Alpha-Synuclein Induced Immune Cells Activation and Associated Therapy in Parkinson's Disease.
- Published in:
- Frontiers in Aging Neuroscience, 2021, v. 13, p. 1, doi. 10.3389/fnagi.2021.769506
- By:
- Publication type:
- Article
Parkinson's Disease Dementia: Synergistic Effects of Alpha-Synuclein, Tau, Beta-Amyloid, and Iron.
- Published in:
- Frontiers in Aging Neuroscience, 2021, v. 13, p. 1, doi. 10.3389/fnagi.2021.743754
- By:
- Publication type:
- Article
Editorial: Biomarkers and Pathogenesis of Alpha-Synuclein in Parkinson's Disease.
- Published in:
- Frontiers in Aging Neuroscience, 2021, v. 13, p. 1, doi. 10.3389/fnagi.2021.776873
- By:
- Publication type:
- Article
Alterations of Erythrocytic Phosphorylated Alpha-Synuclein in Different Subtypes and Stages of Parkinson's Disease.
- Published in:
- Frontiers in Aging Neuroscience, 2021, v. 13, p. 1, doi. 10.3389/fnagi.2021.623977
- By:
- Publication type:
- Article
Alpha-Synuclein as a Biomarker of Parkinson's Disease: Good, but Not Good Enough.
- Published in:
- Frontiers in Aging Neuroscience, 2021, v. 13, p. 1, doi. 10.3389/fnagi.2021.702639
- By:
- Publication type:
- Article
Alpha-Synuclein Post-translational Modifications: Implications for Pathogenesis of Lewy Body Disorders.
- Published in:
- Frontiers in Aging Neuroscience, 2021, v. 13, p. 1, doi. 10.3389/fnagi.2021.690293
- By:
- Publication type:
- Article
Biomarkers and the Role of α-Synuclein in Parkinson's Disease.
- Published in:
- Frontiers in Aging Neuroscience, 2021, v. 13, p. N.PAG, doi. 10.3389/fnagi.2021.645996
- By:
- Publication type:
- Article
Preanalytical Stability of CSF Total and Oligomeric Alpha-Synuclein.
- Published in:
- Frontiers in Aging Neuroscience, 2021, v. 13, p. N.PAG, doi. 10.3389/fnagi.2021.638718
- By:
- Publication type:
- Article
Exogenous Alpha-Synuclein Evoked Parkin Downregulation Promotes Mitochondrial Dysfunction in Neuronal Cells. Implications for Parkinson's Disease Pathology.
- Published in:
- Frontiers in Aging Neuroscience, 2021, p. N.PAG, doi. 10.3389/fnagi.2021.591475
- By:
- Publication type:
- Article
Absence of Uptake and Prion-Like Spreading of Alpha-Synuclein and Tau After Intravitreal Injection of Preformed Fibrils.
- Published in:
- Frontiers in Aging Neuroscience, 2021, v. 12, p. N.PAG, doi. 10.3389/fnagi.2020.614587
- By:
- Publication type:
- Article